Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zevra Therapeutics Inc
Net Issuance of Common Stock Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Net Issuance of Common Stock
$7.9m
CAGR 3-Years
-54%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Issuance of Common Stock
-$1.5B
CAGR 3-Years
6%
CAGR 5-Years
31%
CAGR 10-Years
7%
Bristol-Myers Squibb Co
NYSE:BMY
Net Issuance of Common Stock
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Issuance of Common Stock
-$1B
CAGR 3-Years
-12%
CAGR 5-Years
35%
CAGR 10-Years
14%
Eli Lilly and Co
NYSE:LLY
Net Issuance of Common Stock
-$446.1m
CAGR 3-Years
4%
CAGR 5-Years
39%
CAGR 10-Years
8%

See Also

What is Zevra Therapeutics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
7.9m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Net Issuance of Common Stock amounts to 7.9m USD.

What is Zevra Therapeutics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-20%

The average annual Net Issuance of Common Stock growth rates for Zevra Therapeutics Inc have been -54% over the past three years , -20% over the past five years .

Back to Top